HTG Molecular Diagnostics Inc (HTGMQ)
0.0025
0.00 (0.00%)
USD |
OTCM |
May 10, 16:00
HTG Molecular Diagnostics Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2023 | 6.482 |
| December 31, 2022 | 0.7071 |
| September 30, 2022 | 4.135 |
| June 30, 2022 | 1.551 |
| March 31, 2022 | 0.8028 |
| December 31, 2021 | 0.9948 |
| September 30, 2021 | 0.7037 |
| June 30, 2021 | 0.5752 |
| March 31, 2021 | 0.6858 |
| December 31, 2020 | 0.8002 |
| September 30, 2020 | 0.723 |
| June 30, 2020 | 0.6341 |
| March 31, 2020 | 0.4518 |
| December 31, 2019 | 0.4113 |
| September 30, 2019 | 0.3487 |
| June 30, 2019 | 0.8362 |
| March 31, 2019 | 0.6062 |
| December 31, 2018 | 0.4589 |
| September 30, 2018 | 0.4229 |
| Date | Value |
|---|---|
| June 30, 2018 | 0.3525 |
| March 31, 2018 | 0.3084 |
| December 31, 2017 | -2.861 |
| September 30, 2017 | -1.630 |
| June 30, 2017 | -5.739 |
| March 31, 2017 | -0.9446 |
| December 31, 2016 | -2.106 |
| September 30, 2016 | -5.941 |
| June 30, 2016 | 3.607 |
| March 31, 2016 | 1.494 |
| December 31, 2015 | 0.6391 |
| September 30, 2015 | 0.4794 |
| June 30, 2015 | 0.3881 |
| March 31, 2015 | -0.4975 |
| December 31, 2014 | -0.468 |
| September 30, 2014 | -0.4389 |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | -0.002 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.3487
Minimum
Sep 2019
6.482
Maximum
Mar 2023
1.303
Average
0.715
Median
Debt to Equity Ratio Benchmarks
| Viveve Medical Inc | -- |
| Minerva Surgical Inc | 1.952 |
| Stereotaxis Inc | 0.00 |
| Electromed Inc | 0.00 |
| Myomo Inc | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 10.87M |
| Total Liabilities (Quarterly) | 10.39M |
| Shareholders Equity (Quarterly) | 0.4745M |